A national search process for a new CFO is underway, and Boyd will continue in both posts during the search process, the company said in a statement.
“Jim has been a key member of the senior management team and a highly-regarded leader for the company over the last seven years,” said CEO Kevin Helash.
READ: Marrone Bio and Rizobacter to distribute foliar fertilizer and plant health technology in Argentina, Uruguay, Paraguay and Bolivia
“He has helped guide the company through its successful transition as a market leader in the agricultural biologicals space. On behalf of myself, the board of directors and the entire team at Marrone Bio Innovations, we want to thank Jim for his numerous contributions to the strength of the company and wish him the very best in his retirement,” Helash added.
The CEO said the company is “looking for an exceptional individual to help lead the company during its next phase of accelerated growth while ensuring we are brilliant at the basics that drive operational and financial excellence.”
He added: “We have a solid financial team in place and expect the new CFO to be able to make a rapid transition and add immediate value.”
Boyd said he is “proud to have helped build the company into a world-class organization” with an unmatched product portfolio in sustainable biological products.
“Given our recent revenue growth and margin expansion, I am confident the company is poised to deliver meaningful shareholder value. I look forward to working with our finance team as we make this transition and ensure the company’s continuing success,” Boyd said.
Based in Davis, California, Marrone Bio holds more than 400 issued and pending patents and has brought six US Environmental Protection Agency-registered biological product lines and one biostimulant to market.
Contact the author: [email protected]
Follow him on Twitter @PatrickMGraham